PharmEste's Series A Round

PharmEste raised a round of funding on January 01, 2007.

PharmEste is a private biopharmaceutical company focused on the discovery and development of Transient Receptor Potential (TRP) channel therapeutics for the treatment of neuropathic pain, and other TR…

Articles about PharmEste's Series A Round: